Literature DB >> 21657963

Polymorphisms in folate-related genes: impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese.

Lin Yang1, Liang Liu, Jianxiang Wang, Lugui Qiu, Yingchang Mi, Xiaotang Ma, Zhijian Xiao.   

Abstract

Folate metabolism plays an essential role in the processes of DNA synthesis and methylation. An aberrant folate metabolism caused by a genetic polymorphism may lead to genomic instability and affect the susceptibility to malignancies including acute lymphoblastic leukemia (ALL). This study was designed to explore the correlation between the polymorphisms in folate-related genes and the risk of ALL in Han Chinese. The DNA was isolated from 231 patients with pediatric ALL, 130 patients with adult ALL, and 367 healthy subjects (as controls). Polymorphisms were examined for RFC1 80G > A, DHFR 19 bp del/ins and 317A > G, SHMT1 1420C > T, MTHFR 677C > T and 1298A > C, MTR 2756A > G, MTRR 66A > G, TYMS 3R/2R, MTHFD1 1958G > A, and ABCG2 421G > T using real-time polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism (RFLP). The risk of adult ALL was increased by the RFC1 80AA variant (odds ratio [OR] = 2.09; 95% confidence interval [CI] 1.19-3.67) and MTRR 66GG variant (OR = 2.15; 95% CI 1.06-4.39) but reduced by the MTHFR 677TT variant (OR = 0.47; 95% CI 0.25-0.88), ABCG2 421GT variant (OR = 0.62; 95% CI 0.41-0.96), and ABCG2 421GT + TT variant (OR = 0.60; 95% CI 0.40-0.90). The increase in risk of adult ALL with the RFC1 80AA associated with the MTRR 66GG variant was even more significant (OR = 8.92; 95% CI 1.97-40.42). Furthermore, the MTHFR 677TT associated with the ABCG2 421GT + TT variant more significantly reduced the risk of adult ALL (OR = 0.32; 95% CI 0.12-0.85). However, all gene polymorphisms tested in this study failed to affect the pediatric ALL risk. Our study clearly demonstrates that polymorphisms in folate-related genes only modulate the susceptibility to adult ALL, but not to pediatric ALL, in Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21657963     DOI: 10.3109/10428194.2011.578186

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults.

Authors:  Ping Liu; Min Zhang; Xing Xie; Jie Jin; C D'Arcy J Holman
Journal:  Tumour Biol       Date:  2015-10-05

2.  Gene polymorphisms in the folate metabolic pathway and risk of pediatric acute lymphoblastic leukemia: a case-control study in a Chinese population.

Authors:  Hui Lv; Shao-Yan Hu; Zhi-Zuo Du; Zong Zhai; Lan Cao; Yi-Na Sun; Jun Lu; Jie Li; Hai-Long He; Yi-Huan Chai; Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  Lack of Impact of the A1298C MTHFR on the Risk of Childhood Acute Lymphoblastic Leukemia: Evidence from a Meta-analysis.

Authors:  Rim Frikha
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-26       Impact factor: 0.900

Review 4.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

5.  Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis.

Authors:  Hongtuan Zhang; Hui Ma; Liang Li; Zhihong Zhang; Yong Xu
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

6.  Association of MTRR A66G polymorphism with cancer susceptibility: Evidence from 85 studies.

Authors:  Ping Wang; Sanqiang Li; Meilin Wang; Jing He; Shoumin Xi
Journal:  J Cancer       Date:  2017-01-15       Impact factor: 4.207

7.  Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: a meta-analysis based on 51 case-control studies.

Authors:  Su-yi Li; Jie-yu Ye; En-yu Liang; Li-xia Zhou; Mo Yang
Journal:  Med Sci Monit       Date:  2015-03-12

8.  Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis.

Authors:  Orsolya Lautner-Csorba; András Gézsi; Dániel J Erdélyi; Gábor Hullám; Péter Antal; Ágnes F Semsei; Nóra Kutszegi; Gábor Kovács; András Falus; Csaba Szalai
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 9.  Association Between RFC1 G80A Polymorphism and Acute Lymphoblastic Leukemia: a Review and Meta-Analysis of 10 Studies.

Authors:  M Forat-Yazdi; F Hosseini-Biouki; J Salehi; H Neamatzadeh; R Masoumi Dehshiri; Z Sadri; F Ghanizadeh; R Sheikhpour; H Zare-Zardini
Journal:  Iran J Ped Hematol Oncol       Date:  2016-03-15

10.  The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies.

Authors:  Xiaoyi Huang; Yisha Gao; Jing He; Jiao Cai; Na Ta; Hui Jiang; Jinhong Zhu; Jianming Zheng
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.